Summary Pfizer Inc (Pfizer) is a biopharmaceutical company, which focuses on the discovery, development, manufacture and marketing of healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products in key therapeutic areas including internal medicine, cancer, vaccines, inflammation and immunology and rare diseases. It also provides sterile injectable pharmaceuticals, infusion systems, biosimilars, as well as active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer sells prescription pharmaceutical products through wholesalers, besides selling them directly to retailers, hospitals, clinics, government agencies and pharmacies. It sells consumer healthcare products through pharmacies, retail chains, distributors and grocery and convenience stores. The company provides its products in the US, Canada, Latin America, Asia, Japan, South Korea, New Zealand, Australia, Finland, Scandinavian countries, Africa, the Middle East and Turkey. Pfizer is headquartered in New York, the US. Pfizer Inc (PFE) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and... Research Beam Model: Research Beam Product ID: 1745939 250 USD New
Pfizer Inc (PFE) - Medical Equipment - Deals and Alliances Profile
 
 

Pfizer Inc (PFE) - Medical Equipment - Deals and Alliances Profile

  • Category : Medical Devices
  • Published On : July   2017
  • Pages : 166
  • Publisher : GlobalData
 
 
 
Summary

Pfizer Inc (Pfizer) is a biopharmaceutical company, which focuses on the discovery, development, manufacture and marketing of healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products in key therapeutic areas including internal medicine, cancer, vaccines, inflammation and immunology and rare diseases. It also provides sterile injectable pharmaceuticals, infusion systems, biosimilars, as well as active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer sells prescription pharmaceutical products through wholesalers, besides selling them directly to retailers, hospitals, clinics, government agencies and pharmacies. It sells consumer healthcare products through pharmacies, retail chains, distributors and grocery and convenience stores. The company provides its products in the US, Canada, Latin America, Asia, Japan, South Korea, New Zealand, Australia, Finland, Scandinavian countries, Africa, the Middle East and Turkey. Pfizer is headquartered in New York, the US.

Pfizer Inc (PFE) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Pfizer Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Pfizer Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Pfizer Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Pfizer Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 11
Pfizer Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Pfizer Inc, Medical Equipment, Deal Details 17
Venture Financing 17
Neuronetics Raises USD15 Million in Series G Round of Financing 17
Cordex Systems Raises Funds in Series A Financing 18
Advanced MR Analytics Raises USD9 Million in Venture Financing 20
Molecular Stethoscope Raises USD8.2 Million in Seed Financing 21
RefleXion Medical Raises Additional USD6 Million in Series B Financing 21
RefleXion Medical Raises USD46 Million in Series B Financing 22
UE LifeSciences to Raise USD0.1 Million in Seed Financing 23
RefleXion Medical Raises US$11.6 Million In Series A Round 24
NeuMoDx Raises US$21 Million In Series B Financing 25
Nodality Raises US$15 Million In Venture Financing Round 26
InnoPharma Secures US$15 Million In Series A Financing Round 27
Neuronetics Secures US$30 Million In Series E Financing 28
U-Systems Secures US$6.5 Million In Venture Financing Round 30
Partnerships 31
Pfizer Enters into Licensing Agreement with Scripps Research Institute 31
Pfizer Enters into Licensing Agreement with Pelago Bioscience 32
Ichor Medical Systems Enters Into Licensing Agreement With Pfizer 32
pSivida Amends Licensing Agreement With Pfizer 33
Mirth Enters Into Licensing Agreement With Pfizer Health Solutions 34
InSphero Enters into Agreement with Pfizer 35
Molecular Stethoscope Enters into Research Agreement with Pfizer 36
Iatric Systems Enters into Agreement with Hospira 36
Pfizer Enters into Distribution Agreement Adhezion Biomedical 37
Pfizer Enters into Research Agreement with International Business Machines 38
Medivation and NanoString Technologies Enter into Partnership With Astellas Pharma 39
Thermo Fisher Scientific Enters into Agreement with Novartis and Pfizer 40
Merck and Pfizer Enters into Agreement with Dako 41
Pfizer Enters into Evaluation Agreement with BIRAD 42
Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer 42
Siemens Healthcare Enters Into Co-Development Agreement With Pfizer 44
Protagen Enters Into Biomarker Discovery Agreement With Pfizer 45
MaRS Innovation Enters Into Partnership With Pfizer 45
Dako Enters Into Agreement With Pfizer For Companion Diagnostics 46
Hospira Enters Into Distribution Agreement With Q Core Medical For Sapphire Infusion System 47
Humedica Enters Into Agreement With Pfizer 48
Stellar Pharma Enters Into Co-Marketing Agreement With Pfizer Canada For Gelfoam 49
Ventana Medical Systems Enters Into Co-Development Agreement With Pfizer 49
ICU Medical Extends Distribution Agreement With Hospira For CLAVE And Oncology Products 50
ICU Medical Extends Distribution Agreement With Hospira For Infusion Sets 51
Qiagen Enters Into Co-Development Agreement With Pfizer 52
Resonance Health Enters into Agreement with Pfizer 53
Mylan Specialty Enters Into Licensing Agreement With Pfizer For EpiPen 54
Abbott Labs Enters Into Licensing Agreement With Pfizer 55
Kiadis Pharma Enters Into Licensing Agreement With Hospira For ATIR 55
Debt Offering 56
Pfizer Raises USD1.06 Billion in Private Placement of 4.2% Notes Due 2047 56
Pfizer Raises USD1.3 Billion in Public Offering of Notes Due 2019 58
Pfizer Raises USD793.5 Million in Public Offering of 1% Notes Due 2027 59
Pfizer Raises USD1.06 Billion in Public Offering of Notes Due 2020 61
Pfizer Raises USD1.06 Billion in Public Offering of 0.25% Notes Due 2022 62
Pfizer Raises USD1.3 Billion in Public Offering of 4.125% Notes Due 2046 64
Pfizer Raises USD1 Billion in Public Offering of 1.7% Notes Due 2019 66
Pfizer Raises USD1 Billion in Public Offering of 4% Notes Due 2036 67
Pfizer Raises USD1 Billion in Public Offering of 2.2% Notes Due 2021 69
Pfizer Raises USD1.8 Billion in Public Offering of 3% Notes Due 2026 71
Pfizer Raises USD0.85 Billion in Public Offering of 1.45% Notes Due 2019 73
Pfizer Raises USD1.25 Billion in Public Offering of 2.75% Notes Due 2026 74
Pfizer Raises USD1.25 Billion in Public Offering of 1.2% Notes Due 2018 76
Pfizer Raises USD0.5 Billion in Public Offering of 4.4% Notes Due 2044 77
Pfizer Raises USD1.15 Billion in Public Offering of 1.95% Notes Due 2021 79
Asset Transactions 81
ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 81
Mylan Completes Acquisition Of Respiratory Delivery Platform From Pfizer For US$348 Million 82
True Process Acquires VeriScan, Bar Code And Radio-Frequency Identification System From Hospira 84
Acquisition 84
Pfizer Acquires Hospira for USD17 Billion 84
Pfizer May Acquire Remaining 90.5% Stake in Cellectis 87
Pfizer May Increase Bid to Acquire AstraZeneca 87
Premier Acquires TheraDoc from Hospira for USD117 Million 89
Fluidigm Completes Acquisition Of DVS Sciences For US$207.5 Million 90
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 92
Covidien Completes Acquisition Of superDimension, Pulmonary Device Maker, For US$300 Million 94
Pfizer Inc - Key Competitors 97
Key Employees 98
Locations And Subsidiaries 100
Head Office 100
Other Locations & Subsidiaries 100
Recent Developments 127
Strategy And Business Planning 127
Jun 27, 2017: Pfizer Breaks Ground on New R&D Facility in Chesterfield, Missouri 127
Sep 26, 2016: Pfizer Decides Remaining One Company Best Positions Company To Maximize Future Value Creation 128
Jul 13, 2016: Pfizer and NovaMedica announce a strategic partnership in Russia 129
Jun 16, 2016: Pfizer Breaks Ground On New Biologics Clinical Manufacturing Facility In Andover, Massachusetts 130
Financial Announcements 131
May 02, 2017: Pfizer Reports First-Quarter 2017 Results 131
Jan 31, 2017: Pfizer Reports Fourth-Quarter And Full-Year 2016 Results 135
Nov 01, 2016: Pfizer Reports Third-Quarter 2016 Results 140
Aug 02, 2016: Pfizer Reports Second-Quarter 2016 Results 145
May 03, 2016: Pfizer Reports First-Quarter 2016 Results 149
Feb 02, 2016: Pfizer Reports Fourth-Quarter And Full-Year 2015 Results Provides 2016 Financial Guidance 153
Corporate Communications 158
Jun 28, 2017: Pfizer breaks ground on new R&D facility in Missouri 158
Feb 23, 2017: Ronald E. Blaylock Elected to Pfizer’s Board of Directors 159
Nov 21, 2016: Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply to Retire 160
Sep 07, 2016: Pfizer Appoints Chief Scientific Officer for Neuroscience Research 161
Feb 08, 2016: Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan Transaction 162
Legal and Regulatory 163
Apr 27, 2016: A.G. Schneiderman Announces Multistate And Federal Settlement With Wyeth And Pfizer For $784.6m To Resolve Allegations Of Underpaying Rebates Owed Through The Medicaid Drug Rebate Program 163
Mar 22, 2016: Geisinger Health System receives accreditation from the Association for the Accreditation of Human Research Protection Programs 165
Appendix 166
Methodology 166
About GlobalData 166
Contact Us 166
Disclaimer 166

List of Tables
Pfizer Inc, Medical Equipment, Key Facts, 2016 1
Pfizer Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Pfizer Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Pfizer Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Pfizer Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Pfizer Inc, Deals By Market, 2011 to YTD 2017 11
Pfizer Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Neuronetics Raises USD15 Million in Series G Round of Financing 17
Cordex Systems Raises Funds in Series A Financing 18
Advanced MR Analytics Raises USD9 Million in Venture Financing 20
Molecular Stethoscope Raises USD8.2 Million in Seed Financing 21
RefleXion Medical Raises Additional USD6 Million in Series B Financing 21
RefleXion Medical Raises USD46 Million in Series B Financing 22
UE LifeSciences to Raise USD0.1 Million in Seed Financing 23
RefleXion Medical Raises US$11.6 Million In Series A Round 24
NeuMoDx Raises US$21 Million In Series B Financing 25
Nodality Raises US$15 Million In Venture Financing Round 26
InnoPharma Secures US$15 Million In Series A Financing Round 27
Neuronetics Secures US$30 Million In Series E Financing 28
U-Systems Secures US$6.5 Million In Venture Financing Round 30
Pfizer Enters into Licensing Agreement with Scripps Research Institute 31
Pfizer Enters into Licensing Agreement with Pelago Bioscience 32
Ichor Medical Systems Enters Into Licensing Agreement With Pfizer 32
pSivida Amends Licensing Agreement With Pfizer 33
Mirth Enters Into Licensing Agreement With Pfizer Health Solutions 34
InSphero Enters into Agreement with Pfizer 35
Molecular Stethoscope Enters into Research Agreement with Pfizer 36
Iatric Systems Enters into Agreement with Hospira 36
Pfizer Enters into Distribution Agreement Adhezion Biomedical 37
Pfizer Enters into Research Agreement with International Business Machines 38
Medivation and NanoString Technologies Enter into Partnership With Astellas Pharma 39
Thermo Fisher Scientific Enters into Agreement with Novartis and Pfizer 40
Merck and Pfizer Enters into Agreement with Dako 41
Pfizer Enters into Evaluation Agreement with BIRAD 42
Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer 42
Siemens Healthcare Enters Into Co-Development Agreement With Pfizer 44
Protagen Enters Into Biomarker Discovery Agreement With Pfizer 45
MaRS Innovation Enters Into Partnership With Pfizer 45
Dako Enters Into Agreement With Pfizer For Companion Diagnostics 46
Hospira Enters Into Distribution Agreement With Q Core Medical For Sapphire Infusion System 47
Humedica Enters Into Agreement With Pfizer 48
Stellar Pharma Enters Into Co-Marketing Agreement With Pfizer Canada For Gelfoam 49
Ventana Medical Systems Enters Into Co-Development Agreement With Pfizer 49
ICU Medical Extends Distribution Agreement With Hospira For CLAVE And Oncology Products 50
ICU Medical Extends Distribution Agreement With Hospira For Infusion Sets 51
Qiagen Enters Into Co-Development Agreement With Pfizer 52
Resonance Health Enters into Agreement with Pfizer 53
Mylan Specialty Enters Into Licensing Agreement With Pfizer For EpiPen 54
Abbott Labs Enters Into Licensing Agreement With Pfizer 55
Kiadis Pharma Enters Into Licensing Agreement With Hospira For ATIR 55
Pfizer Raises USD1.06 Billion in Private Placement of 4.2% Notes Due 2047 56
Pfizer Raises USD1.3 Billion in Public Offering of Notes Due 2019 58
Pfizer Raises USD793.5 Million in Public Offering of 1% Notes Due 2027 59
Pfizer Raises USD1.06 Billion in Public Offering of Notes Due 2020 61
Pfizer Raises USD1.06 Billion in Public Offering of 0.25% Notes Due 2022 62
Pfizer Raises USD1.3 Billion in Public Offering of 4.125% Notes Due 2046 64
Pfizer Raises USD1 Billion in Public Offering of 1.7% Notes Due 2019 66
Pfizer Raises USD1 Billion in Public Offering of 4% Notes Due 2036 67
Pfizer Raises USD1 Billion in Public Offering of 2.2% Notes Due 2021 69
Pfizer Raises USD1.8 Billion in Public Offering of 3% Notes Due 2026 71
Pfizer Raises USD0.85 Billion in Public Offering of 1.45% Notes Due 2019 73
Pfizer Raises USD1.25 Billion in Public Offering of 2.75% Notes Due 2026 74
Pfizer Raises USD1.25 Billion in Public Offering of 1.2% Notes Due 2018 76
Pfizer Raises USD0.5 Billion in Public Offering of 4.4% Notes Due 2044 77
Pfizer Raises USD1.15 Billion in Public Offering of 1.95% Notes Due 2021 79
ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 81
Mylan Completes Acquisition Of Respiratory Delivery Platform From Pfizer For US$348 Million 82
True Process Acquires VeriScan, Bar Code And Radio-Frequency Identification System From Hospira 84
Pfizer Acquires Hospira for USD17 Billion 84
Pfizer May Acquire Remaining 90.5% Stake in Cellectis 87
Pfizer May Increase Bid to Acquire AstraZeneca 87
Premier Acquires TheraDoc from Hospira for USD117 Million 89
Fluidigm Completes Acquisition Of DVS Sciences For US$207.5 Million 90
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 92
Covidien Completes Acquisition Of superDimension, Pulmonary Device Maker, For US$300 Million 94
Pfizer Inc, Key Competitors 97
Pfizer Inc, Key Employees 98
Pfizer Inc, Subsidiaries 100
List of Figures
Pfizer Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Pfizer Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Pfizer Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Pfizer Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Pfizer Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Pfizer Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 9
Pfizer Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Pfizer Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 11
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter